Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07384585 · ClinicalTrials.gov registry record · NA

Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)

A NA study of Circadian Dysregulation and Light Exposure, sponsored by Laura Beth Kalvas.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07384585: Recruiting NA study of Circadian Dysregulation and Light Exposure, sponsored by Laura Beth Kalvas.

NCT07384585 is a NA study of Circadian Dysregulation and Light Exposure that is actively recruiting participants, run by Laura Beth Kalvas. The registered enrollment target is 30 participants, below the 68-participant average among 10 other Circadian Dysregulation trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07384585, a NA study of Circadian Dysregulation and Light Exposure, is actively recruiting participants, sponsored by Laura Beth Kalvas.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to understand how easy or difficult it is for critically ill children (4-17 years old) to have light therapy while in the pediatric ICU. Participants will have a light meter at their bedside to measure light levels. Each morning, a light box will be placed at their bedside. Children, family, and staff will be asked to completed feedback surveys regarding the light therapy. Study participation will continue for a maximum of 5 days.

Primary Outcome

Feasibility of light therapy assessed via feedback surveys from children, families, and clinical staff.

Interventions

  • OTHER Light Therapy

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-03
Est. Completion 2027-01
Phase NA
Laura Beth Kalvas

1 total trials

What NCT07384585 shows while recruiting

NCT07384585 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 68-participant average among 10 other Circadian Dysregulation trials with a reported enrollment target (56% lower).

The record links to 3 conditions, with Circadian Dysregulation appearing as the primary indexed condition, and to 1 intervention - of which Light Therapy is the first listed.

NCT07384585 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07384585 about?

NCT07384585 is a clinical study titled "Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)". The goal of this clinical trial is to understand how easy or difficult it is for critically ill children (4-17 years old) to have light therapy while in the pediatric ICU. Participants will have a light meter at their bedside to measure light levels. Each morning, a light box will be placed at their...

What is the current status of trial NCT07384585?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03. Estimated completion is 2027-01.

What conditions does trial NCT07384585 study?

This clinical trial studies the following conditions: Circadian Dysregulation, Light Exposure, Pediatric Critical Illness.

What interventions are being tested in trial NCT07384585?

The interventions under investigation include: Light Therapy (OTHER).

Who is sponsoring clinical trial NCT07384585?

This trial is sponsored by Laura Beth Kalvas, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07384585 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Circadian Dysregulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07384585's enrollment target sits among peer trials

30 6th of 10 higher than 5 of 10 other Circadian Dysregulation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Circadian Dysregulation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07384585, the US trial registry maintained by the National Library of Medicine. NCT07384585 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.